- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Adicet Bio Inc (ACET)
Adicet Bio Inc stock price live, this page displays NASDAQ ACET stock exchange data. View the ACET premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Adicet Bio Inc real time stock price chart below.
What Is the Adicet Bio Inc Stock Price Today?
The Adicet Bio Inc stock price today is 0.563.
What Is the Stock Symbol for Adicet Bio Inc?
The stock symbol for Adicet Bio Inc is ""ACET.""
What Stock Exchange Does Adicet Bio Inc Trade On?
Adicet Bio Inc is listed and trades on the NASDAQ stock exchange.
Is Adicet Bio Inc a Good Stock to Buy?
Determining whether Adicet Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ACET quote. (ISIN: US0070021086)
What Is the Adicet Bio Inc Stock Price Today?
The Adicet Bio Inc stock price today is 0.563.
What Is the Stock Symbol for Adicet Bio Inc?
The stock symbol for Adicet Bio Inc is ""ACET.""
What Stock Exchange Does Adicet Bio Inc Trade On?
Adicet Bio Inc is listed and trades on the NASDAQ stock exchange.
Is Adicet Bio Inc a Good Stock to Buy?
Determining whether Adicet Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ACET quote. (ISIN: US0070021086)
NASDAQ
Currency in USD
0.563
-0.047(-7.73%)
Real-time Data·
Fair Value
An estimate of a Adicet Bio's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.548
0.615
52 wk Range
0.447
1.130
ACET is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Adicet Bio's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.5480.615
52 wk Range
0.4471.130
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ACET Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Adicet Bio's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
7.167
Upside
+1,172.94%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
4 analysts have revised their earnings upwards for the upcoming period
- Form 6K Adicet Bio Inc For: 27 October
- Investing.com
- Form DEF 14A Adicet Bio For: 17 November
- Investing.com
- Form DEF 14A Adicet Bio For: 17 November
- Investing.com
- resTORbio receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form PRE 14A Adicet Bio For: 5 November
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Adicet Bio Inc Company Profile
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. It offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients. The company’s lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the potential treatment of autoimmune diseases and relapsed/refractory B-cell non-hodgkin’s lymphoma. It also develops ADI-270, an armored gamma delta CAR T cell product candidate to treat multiple CD70+ solid tumor and hematological malignancies indications, with renal cell carcinoma. The company was founded in 2014 and is based in Boston, Massachusetts.
Adicet Bio Inc SWOT Analysis
Gamma-Delta Pionee | Adicet Bio leads in engineered gamma-delta T cell therapies, with promising candidates for lupus nephritis and renal cell carcinoma in Phase 1 trials |
Financial Fortitude | Strong cash position of $150.4M supports ongoing clinical trials, though rapid cash burn rate poses future funding challenges |
Expanding Horizons | Explore Adicet's ambitious pipeline expansion into multiple autoimmune conditions, showcasing the versatility of its innovative platform |
Market Valuation | With analyst price targets ranging from $4 to $8 per share, Adicet's current trading price of $0.69 presents a potential asymmetric upside opportunity |
Compare ACET to Peers and Sector
Metrics to compare | ACET | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipACETPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.8x | −2.9x | −0.6x | |
PEG Ratio | −0.04 | 0.07 | 0.00 | |
Price/Book | 0.8x | 1.7x | 2.6x | |
Price / LTM Sales | - | 10.1x | 3.3x | |
Upside (Analyst Target) | - | 433.2% | 40.1% | |
Fair Value Upside | Unlock | 17.5% | 5.8% | Unlock |
Analyst Ratings
7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 7.167
(+1,172.94% Upside)
Earnings
Latest Release
Nov 05, 2025
EPS / Forecast
-0.29 / -0.30
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Adicet Bio (ACET) Premarket Price Today?
The Adicet Bio (ACET) premarket price is 0.623. Premarket price change units: 0.013. Premarket percentage change: 2.130%. Premarket volume: 6,010.000. Current date: 02 Dec 2025. Previous close: 0.610
What Stock Exchange Does Adicet Bio Trade On?
Adicet Bio is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Adicet Bio?
The stock symbol for Adicet Bio is "ACET."
What Is the Adicet Bio (ACET) Afterhours Price Today? (Afterhours variable test: 0.607) Current Date: 02 Dec 2025
After hours price: 0.607. After hours price change (units): -0.003. Price change percentage: -0.520%
What Is the Adicet Bio Market Cap?
As of today, Adicet Bio market cap is 91.04M.
What Is Adicet Bio's Earnings Per Share (TTM)?
The Adicet Bio EPS (TTM) is -1.26.
When Is the Next Adicet Bio Earnings Date?
Adicet Bio will release its next earnings report on 04 Mar 2026.
From a Technical Analysis Perspective, Is ACET a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Adicet Bio Stock Split?
Adicet Bio has split 1 times.
How Many Employees Does Adicet Bio Have?
Adicet Bio has 152 employees.
What is the current trading status of Adicet Bio (ACET)?
As of 02 Dec 2025, Adicet Bio (ACET) is trading at a price of 0.563, with a previous close of 0.610. The stock has fluctuated within a day range of 0.548 to 0.615, while its 52-week range spans from 0.447 to 1.130.
What Is Adicet Bio (ACET) Price Target According to Analysts?
The average 12-month price target for Adicet Bio is USD7.16667, with a high estimate of USD9 and a low estimate of USD5. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +1,172.94% Upside potential.
What Is the ACET Premarket Price?
ACET's last pre-market stock price is 0.623. The pre-market share volume is 6,010.000, and the stock has decreased by 0.013, or 2.130%.
What Is the ACET After Hours Price?
ACET's last after hours stock price is 0.607, the stock has decreased by -0.003, or -0.520%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.